Skip to main content

Advertisement

SpringerLink
Log in

Inflammatory Biomarkers and Depression

  • Published:
Neurotoxicity Research Aims and scope Submit manuscript

Abstract

Antidepressants, predominantly serotonin- and/or noradrenaline reuptake inhibiting drugs have several shortcomings. The exact pathophysiological mechanisms leading to serotonergic-, noradrenergic- or dopaminergic dysfunction are still unclear. An inflammatory mechanism has been postulated and will be discussed here including possible therapeutic advantages of cyclooxygenase-2 (COX-2) inhibitors. Differences in the activation of the enzyme indoleamine 2,3-dioxygenase (IDO) and in the tryptophan–kynurenine metabolism resulting in an increased tryptophan and serotonin degradation and probably in an increased production of quinolinic acid might play a key role in major depression (MD). These differences are associated with an imbalance in the glutamatergic neurotransmission, which may contribute to an overweight of N-methyl-d-aspartate agonism in MD. The immunological imbalance results in an increased prostaglandin E2 production and probably also in an increased COX-2 expression. Although there is strong evidence for the view that the interactions of the immune system, IDO, the serotonergic system and the glutamatergic neurotransmission play a key role in MD, several gaps, e.g. the roles of genetics, disease course, sex, different psychopathological states, etc., have to be bridged by intense further research. There were already hints that anti-inflammatory therapy might have beneficial effects in MD. COX-2 inhibitors, however, have been tested in animal models and in preliminary clinical studies showing favourable effects compared to placebo in MD. The effects of COX-2 inhibition in the CNS as well as the different components of the inflammatory system, the kynurenine-metabolism and the glutamatergic neurotransmission, however, still need careful further scientific evaluation including clinical studies in bigger samples of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Akhondzadeh S, Jafari S, Raisi F et al (2009) A clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depress Anxiety 26:607–611

    CAS  PubMed  Google Scholar 

  • Alberati GD, Ricciardi CP, Kohler C, Cesura AM (1996) Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells. J Neurochem 66:996–1004

    Google Scholar 

  • Altamura CA, Mauri MC, Ferrara A, Moro AR, D’Andrea G, Zamberlan F (1993) Plasma and platelet excitatory amino acids in psychiatric disorders. Am J Psychiatry 150:1731–1733

    CAS  PubMed  Google Scholar 

  • Bacher M, Meinhardt A, Lan HY, Dhabhar FS, Mu W, Metz CN, Chesney JA, Gemsa D, Donnelly T, Atkins RC, Bucala R (1998) MIF expression in the rat brain: implications for neuronal function. Mol Med 4:217–230

    CAS  PubMed  Google Scholar 

  • Banks WA, Kastin AJ, Broadwell RD (1995) Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 2:241–248

    CAS  PubMed  Google Scholar 

  • Baron DA, Hardie T, Baron SH (1993) Possible association of interleukin-2 treatment with depression and suicide. J Am Osteopath Assoc 93:799–800

    CAS  PubMed  Google Scholar 

  • Begemann M, Sargin D, Rossner MJ, Bartels C, Theis F, Wichert SP, Stender N, Fischer B, Sperling S, Stawicki S, Wiedl A, Falkai P, Nave KA, Ehrenreich H (2008) Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches. Mol Med 14:546–552

    CAS  PubMed  Google Scholar 

  • Berk M, Wadee AA, Kuschke RH, O’Neill-Kerr A (1997) Acute phase proteins in major depression. J Psychosom Res 43:529–534

    CAS  PubMed  Google Scholar 

  • Berkenbosch F, van Oers J, del Rey A, Tilders F, Besedovsky H (1987) Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 238:524–526

    CAS  PubMed  Google Scholar 

  • Besedovsky H, del Rey A, Sorkin E, Dinarello CA (1986) Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233:652–654

    CAS  PubMed  Google Scholar 

  • Bonaccorso S, Lin AH, Verkerk R, Van Hunsel F, Libbrecht I, Scharpe S, DeClerck L, Biondi M, Janca A, Maes M (1998) Immune markers in fibromyalgia: comparison with major depressed patients and normal volunteers. J Affect Disord 48:75–82

    CAS  PubMed  Google Scholar 

  • Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M, Almerighi C, Verkerk R, Meltzer H, Maes M (2002) Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. J Clin Psychopharmacol 22:86–90

    CAS  PubMed  Google Scholar 

  • Brambilla F, Maggioni M (1998) Blood levels of cytokines in elderly patients with major depressive disorder. Acta Psychiatr Scand 97:309–313

    CAS  PubMed  Google Scholar 

  • Brambilla F, Monteleone P, Maj M (2004) Interleukin-1beta and tumor necrosis factor-alpha in children with major depressive disorder or dysthymia. J Affect Disord 78:273–277

    CAS  PubMed  Google Scholar 

  • Braun D, Longman RS, Albert ML (2005) A two-step induction of indoleamine 2,3-dioxygenase (IDO) activity during dendritic-cell maturation. Blood 106:2375–2381

    CAS  PubMed  Google Scholar 

  • Brunello N, Alboni S, Capone G, Benatti C, Blom JM, Tascedda F, Kriwin P, Mendlewicz J (2006) Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depression. Int Clin Psychopharmacol 21:219–225

    PubMed  Google Scholar 

  • Buchanan RW, Javitt DC, Marder SR, Schooler NR, Gold JM, McMahon RP, Heresco-Levy U, Carpenter WT (2007) The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. Am J Psychiatry 164:1593–1602

    PubMed  Google Scholar 

  • Burke HM, Davis MC, Otte C, Mohr DC (2005) Depression and cortisol responses to psychological stress: a meta-analysis. Psychoneuroendocrinology 30:846–856

    CAS  PubMed  Google Scholar 

  • Calabrese JR, Skwerer RG, Barna B, Gulledge AD, Valenzuela R, Butkus A, Subichin S, Krupp NE (1986) Depression, immunocompetence, and prostaglandins of the E series. Psychiatry Res 17:41–47

    CAS  PubMed  Google Scholar 

  • Campbell S, Macqueen G (2004) The role of the hippocampus in the pathophysiology of major depression. J Psychiatry Neurosci 29:417–426

    PubMed  Google Scholar 

  • Cao C, Matsumura K, Ozaki M, Watanabe Y (1999) Lipopolysaccharide injected into the cerebral ventricle evokes fever through induction of cyclooxygenase-2 in brain endothelial cells. J Neurosci 19:716–725

    CAS  PubMed  Google Scholar 

  • Capuron L, Neurauter G, Musselman DL, Lawson DH, Nemeroff CB, Fuchs D, Miller AH (2003) Interferon-alpha-induced changes in tryptophan metabolism. Relationship to depression and paroxetine treatment. Biol Psychiatry 54:906–914

    CAS  PubMed  Google Scholar 

  • Casolini P, Catalani A, Zuena AR, Angelucci L (2002) Inhibition of COX-2 reduces the age-dependent increase of hippocampal inflammatory markers, corticosterone secretion, and behavioral impairments in the rat. J Neurosci Res 68:337–343

    CAS  PubMed  Google Scholar 

  • Cizza G, Eskandari F, Coyle M, Krishnamurthy P, Wright EC, Mistry S, Csako G (2009) Plasma CRP levels in premenopausal women with major depression: a 12-month controlled study. Horm Metab Res 41:641–648

    Google Scholar 

  • Collantes-Esteves E, Fernandez-Perrez Ch (2003) Improved self-control of ostheoarthritis pain and self-reported health status in non-responders to celecoxib switched to rofecoxib: results of PAVIA, an open-label post-marketing survey in Spain. Curr Med Res Opin 19:402–410

    Google Scholar 

  • Coppen A, Swade C (1988) 5-HT and depression: the present position. In: Briley M, Fillion G (eds) New concepts in depression. MacMillan Press, London, pp 120–136

    Google Scholar 

  • Coric V, Milanovic S, Wasylink S, Patel P, Malison R, Krystal JH (2003) Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder. Psychopharmacology (Berl) 167:219–220

    CAS  Google Scholar 

  • Crane GE (1959) Cyloserine as an antidepressant agent. Am J Psychiatry 115:1025–1026

    CAS  PubMed  Google Scholar 

  • Danner M, Kasl SV, Abramson JL, Vaccarino V (2003) Association between depression and elevated C-reactive protein. Psychosom Med 65:347–356

    CAS  PubMed  Google Scholar 

  • Dantzer R (2001) Cytokine-induced sickness behavior: where do we stand? Brain Behav Immun 15:7–24

    CAS  PubMed  Google Scholar 

  • Drexhage RC, Knijff EM, Padmos RC, Heul-Nieuwenhuijzen L, Beumer W, Versnel MA, Drexhage HA (2010) The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder. Expert Rev Neurother 10:59–76

    CAS  PubMed  Google Scholar 

  • Duch DS, Woolf JH, Nichol CA, Davidson JR, Garbutt JC (1984) Urinary excretion of biopterin and neopterin in psychiatric disorders. Psychiatry Res 11:83–89

    CAS  PubMed  Google Scholar 

  • Dunbar PR, Hill J, Neale TJ, Mellsop GW (1992) Neopterin measurement provides evidence of altered cell-mediated immunity in patients with depression, but not with schizophrenia. Psychol Med 22:1051–1057

    CAS  PubMed  Google Scholar 

  • Ershler WB, Sun WH, Binkley N, Gravenstein S, Volk MJ, Kamoske G, Klopp RG, Roecker EB, Daynes RA, Weindruch R (1993) Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymphokine Cytokine Res 12:225–230

    CAS  PubMed  Google Scholar 

  • Fertuzinhos SM, Oliveira JR, Nishimura AL, Pontual D, Carvalho DR, Sougey EB, Otto PA, Zatz M (2004) Analysis of IL-1alpha, IL-1beta, and IL-1RA [correction of IL-RA] polymorphisms in dysthymia. J Mol Neurosci 22:251–256

    CAS  PubMed  Google Scholar 

  • Ford DE, Erlinger TP (2004) Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 164:1010–1014

    PubMed  Google Scholar 

  • Frizzo ME, Dall’Onder LP, Dalcin KB, Souza DO (2004) Riluzole enhances glutamate uptake in rat astrocyte cultures. Cell Mol Neurobiol 24:123–128

    CAS  PubMed  Google Scholar 

  • Frommberger UH, Bauer J, Haselbauer P, Fraulin A, Riemann D, Berger M (1997) Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neurosci 247:228–233

    CAS  PubMed  Google Scholar 

  • Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448–454

    CAS  PubMed  Google Scholar 

  • Gimeno D, Marmot MG, Singh-Manoux A (2008) Inflammatory markers and cognitive function in middle-aged adults: the Whitehall II study. Psychoneuroendocrinology 33:1322–1334

    CAS  PubMed  Google Scholar 

  • Haack M, Hinze-Selch D, Fenzel T, Kraus T, Kuhn M, Schuld A, Pollmacher T (1999) Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. J Psychiatr Res 33:407–418

    CAS  PubMed  Google Scholar 

  • Häfner S, Baghai TC, Eser D, Schule C, Rupprecht R, Bondy B, Bedarida G, von SC (2008) C-reactive protein is associated with polymorphisms of the angiotensin-converting enzyme gene in major depressed patients. J Psychiatr Res 42:163–165

    PubMed  Google Scholar 

  • Hasler G, Drevets WC, Manji HK, Charney DS (2004) Discovering endophenotypes for major depression. Neuropsychopharmacology 29:1765–1781

    CAS  PubMed  Google Scholar 

  • Herbert TB, Cohen S (1993) Depression and immunity: a meta-analytic review. Psychol Bull 113:472–486

    CAS  PubMed  Google Scholar 

  • Hestad KA, Tonseth S, Stoen CD, Ueland T, Aukrust P (2003) Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. J ECT 19:183–188

    PubMed  Google Scholar 

  • Himmerich H, Fulda S, Linseisen J, Seiler H, Wolfram G, Himmerich S, Gedrich K, Kloiber S, Lucae S, Ising M, Uhr M, Holsboer F, Pollmacher T (2008) Depression, comorbidities and the TNF-alpha system. Eur Psychiatry 23:421–429

    CAS  PubMed  Google Scholar 

  • Hu F, Wang X, Pace TW, Wu H, Miller AH (2005) Inhibition of COX-2 by celecoxib enhances glucocorticoid receptor function. Mol Psychiatry 10:426–428

    CAS  PubMed  Google Scholar 

  • Huber TJ, Dietrich DE, Emrich HM (1999) Possible use of amantadine in depression. Pharmacopsychiatry 32:47–55

    CAS  PubMed  Google Scholar 

  • Irwin M (1999) Immune correlates of depression. Adv Exp Med Biol 461:1–24

    CAS  PubMed  Google Scholar 

  • Jun TY, Pae CU, Hoon H, Chae JH, Bahk WM, Kim KS, Serretti A (2003) Possible association between -G308A tumour necrosis factor-alpha gene polymorphism and major depressive disorder in the Korean population. Psychiatr Genet 13:179–181

    PubMed  Google Scholar 

  • Katila H, Appelberg B, Hurme M, Rimon R (1994) Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disorders. Schizophr Res 12:29–34

    CAS  PubMed  Google Scholar 

  • Kim JS, Schmid-Burgk W, Claus D, Kornhuber HH (1982) Increased serum glutamate in depressed patients. Arch Psychiatr Nervenkr 232:299–304

    CAS  PubMed  Google Scholar 

  • Kling MA, Alesci S, Csako G, Costello R, Luckenbaugh DA, Bonne O, Duncko R, Drevets WC, Manji HK, Charney DS, Gold PW, Neumeister A (2007) Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A. Biol Psychiatry 62:309–313

    CAS  PubMed  Google Scholar 

  • Kudoh A, Takahira Y, Katagai H, Takazawa T (2002) Small-dose ketamine improves the postoperative state of depressed patients. Anesth Analg 95:114–118 Table

    CAS  PubMed  Google Scholar 

  • Kugaya A, Sanacora G (2005) Beyond monoamines: glutamatergic function in mood disorders. CNS Spectr 10:808–819

    PubMed  Google Scholar 

  • Kwidzinski E, Bunse J, Aktas O, Richter D, Mutlu L, Zipp F, Nitsch R, Bechmann I (2005) Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation. FASEB J 19:1347–1349

    CAS  PubMed  Google Scholar 

  • Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H (2000) Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22:370–379

    CAS  PubMed  Google Scholar 

  • Leonard BE, Myint A (2006) Inflammation and depression: is there a causal connection with dementia? Neurotox Res 10:149–160

    CAS  PubMed  Google Scholar 

  • Lidberg L, Belfrage H, Bertilsson L, Evenden MM, Asberg M (2000) Suicide attempts and impulse control disorder are related to low cerebrospinal fluid 5-HIAA in mentally disordered violent offenders. Acta Psychiatr Scand 101:395–402

    CAS  PubMed  Google Scholar 

  • Lin PY, Su KP (2007) A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry 68:1056–1061

    CAS  PubMed  Google Scholar 

  • Linnoila M, Whorton AR, Rubinow DR, Cowdry RW, Ninan PT, Waters RN (1983) CSF prostaglandin levels in depressed and schizophrenic patients. Arch Gen Psychiatry 40:405–406

    CAS  PubMed  Google Scholar 

  • Madrigal JL, Garcia-Bueno B, Moro MA, Lizasoain I, Lorenzo P, Leza JC (2003) Relationship between cyclooxygenase-2 and nitric oxide synthase-2 in rat cortex after stress. Eur J Neurosci 18:1701–1705

    PubMed  Google Scholar 

  • Maes M, Scharpe S, Meltzer HY, Bosmans E, Suy E, Calabrese J, Cosyns P (1993) Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res 49:11–27

    CAS  PubMed  Google Scholar 

  • Maes M, Scharpe S, Meltzer HY, Okayli G, Bosmans E, D’Hondt P, Vanden Bossche BV, Cosyns P (1994) Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response. Psychiatry Res 54:143–160

    CAS  PubMed  Google Scholar 

  • Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R (1995a) Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 34:301–309

    CAS  PubMed  Google Scholar 

  • Maes M, Meltzer HY, Buckley P, Bosmans E (1995b) Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression. Eur Arch Psychiatry Clin Neurosci 244:325–329

    CAS  PubMed  Google Scholar 

  • Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H (1997) Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9:853–858

    CAS  PubMed  Google Scholar 

  • Maes M, Verkerk R, Vandoolaeghe E, Lin A, Scharpe S (1998) Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity. Acta Psychiatr Scand 97:302–308

    CAS  PubMed  Google Scholar 

  • Maj J, Rogoz Z, Skuza G, Sowinska H (1992) Effects of MK-801 and antidepressant drugs in the forced swimming test in rats. Eur Neuropsychopharmacol 2:37–41

    CAS  PubMed  Google Scholar 

  • Mann JJ, Malone KM (1997) Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients. Biol Psychiatry 41:162–171

    CAS  PubMed  Google Scholar 

  • Martin P, Carlsson ML, Hjorth S (1998) Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats. Neuroreport 9:2985–2988

    CAS  PubMed  Google Scholar 

  • Matussek N (1966) Neurobiologie und depression. Med Monatsschr 3:109–112

    Google Scholar 

  • Matussek N (1988) Catecholamines and mood: neuroendocrine aspects. In: Ganten D, Pfaff D (eds) Current topics in neuroendocrinology. Springer, Heidelberg, pp 141–181

  • Mauri MC, Ferrara A, Boscati L, Bravin S, Zamberlan F, Alecci M, Invernizzi G (1998) Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment. Neuropsychobiology 37:124–129

    CAS  PubMed  Google Scholar 

  • Mellor AL, Munn DH (1999) Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol Today 20:469–473

    CAS  PubMed  Google Scholar 

  • Mendlewicz J, Kriwin P, Oswald P, Souery D, Alboni S, Brunello N (2006) Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study. Int Clin Psychopharmacol 21:227–231

    PubMed  Google Scholar 

  • Mendlovic S, Mozes E, Eilat E, Doron A, Lereya J, Zakuth V, Spirer Z (1999) Immune activation in non-treated suicidal major depression. Immunol Lett 67:105–108

    CAS  PubMed  Google Scholar 

  • Mikova O, Yakimova R, Bosmans E, Kenis G, Maes M (2001) Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur Neuropsychopharmacol 11:203–208

    CAS  PubMed  Google Scholar 

  • Moghaddam B, Bolinao ML, Stein-Behrens B, Sapolsky R (1994) Glucocorticoids mediate the stress-induced extracellular accumulation of glutamate. Brain Res 655:251–254

    CAS  PubMed  Google Scholar 

  • Müller N, Schwarz MJ (2002) Immunology in anxiety and depression. In: Kasper S, den Boer JA, Sitsen JMA (eds) Handbook of depression and anxiety. Marcel Dekker, New York, pp 267–288

    Google Scholar 

  • Müller N, Schwarz MJ (2007a) The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry 12:988–1000

    PubMed  Google Scholar 

  • Müller N, Schwarz MJ (2007b) The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view. J Neurotransmission Suppl 72:269–280

    Google Scholar 

  • Müller N, Hofschuster E, Ackenheil M, Mempel W, Eckstein R (1993) Investigations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis. Prog Neuropsychopharmacol Biol Psychiatry 17:713–730

    PubMed  Google Scholar 

  • Müller N, Riedel M, Scheppach C, Brandstätter B, Sokullu S, Krampe K, Ulmschneider M, Engel RR, Möller HJ, Schwarz MJ (2002) Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am J Psychiatry 159:1029–1034

    PubMed  Google Scholar 

  • Müller N, Schwarz MJ, Dehning S, Douhet A, Cerovecki A, Goldstein-Müller B, Spellmann I, Hetzel G, Maino K, Kleindienst N, Möller HJ, Arolt V, Riedel M (2006) The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 11:680–684

    PubMed  Google Scholar 

  • Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL (1999) Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 189:1363–1372

    CAS  PubMed  Google Scholar 

  • Myint AM, Steinbusch HW, Goeghegan L, Luchtman D, Kim YK, Leonard BE (2007) Effect of the COX-2 inhibitor celecoxib on behavioural and immune changes in an olfactory bulbectomised rat model of depression. Neuroimmunomodulation 14:65–71

    CAS  PubMed  Google Scholar 

  • Nair A, Bonneau RH (2006) Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation. J Neuroimmunol 171:72–85

    CAS  PubMed  Google Scholar 

  • Nassberger L, Traskman-Bendz L (1993) Increased soluble interleukin-2 receptor concentrations in suicide attempters. Acta Psychiatr Scand 88:48–52

    CAS  PubMed  Google Scholar 

  • Nery FG, Monkul ES, Hatch JP, Fonseca M, Zunta-Soares GB, Frey BN, Bowden CL, Soares JC (2008) Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study. Hum Psychopharmacol 23:87–94

    CAS  PubMed  Google Scholar 

  • Nguyen KT, Deak T, Owens SM, Kohno T, Fleshner M, Watkins LR, Maier SF (1998) Exposure to acute stress induces brain interleukin-1beta protein in the rat. J Neurosci 18:2239–2246

    CAS  PubMed  Google Scholar 

  • Niino M, Ogata A, Kikuchi S, Tashiro K, Nishihira J (2000) Macrophage migration inhibitory factor in the cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Behcet’s disease. J Neurol Sci 179:127–131

    CAS  PubMed  Google Scholar 

  • Nordstrom P, Samuelsson M, Asberg M, Traskman BL, Aberg WA, Nordin C, Bertilsson L (1994) CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat Behav 24:1–9

    CAS  PubMed  Google Scholar 

  • Nowak G, Ordway GA, Paul IA (1995) Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims. Brain Res 675:157–164

    CAS  PubMed  Google Scholar 

  • Nudmamud-Thanoi S, Reynolds GP (2004) The NR1 subunit of the glutamate/NMDA receptor in the superior temporal cortex in schizophrenia and affective disorders. Neurosci Lett 372:173–177

    CAS  PubMed  Google Scholar 

  • Nunes SOV, Reiche EMV, Morimoto HK, Matsuo T, Itano EN, Xavier ECD, Yamashita CM, Vieira VR, Menoli AV, Silva SS, Costa FB, Reiche FV, Silva FLV, Kaminami MS (2002) Immune and hormonal activity in adults suffering from depression. Braz J Med Biol Res 35:581–587

    CAS  PubMed  Google Scholar 

  • O’Brien SM, Scott LV, Dinan TG (2004) Cytokines: abnormalities in major depression and implications for pharmacological treatment. Hum Psychopharmacol 19:397–403

    PubMed  Google Scholar 

  • Ohishi K, Ueno R, Nishino S, Sakai T, Hayaishi O (1988) Increased level of salivary prostaglandins in patients with major depression. Biol Psychiatry 23:326–334

    CAS  PubMed  Google Scholar 

  • Olsson SK, Andersson AS, Linderholm KR, Holtze M, Nilsson-Todd LK, Schwieler L, Olsson E, Larsson K, Engberg G, Erhardt S (2009) Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia. Int J Neuropsychopharmacol 12:501–512

    CAS  PubMed  Google Scholar 

  • Ossowska G, Klenk-Majewska B, Szymczyk G (1997) The effect of NMDA antagonists on footshock-induced fighting behavior in chronically stressed rats. J Physiol Pharmacol 48:127–135

    CAS  PubMed  Google Scholar 

  • Ostroff R, Gonzales M, Sanacora G (2005) Antidepressant effect of ketamine during ECT. Am J Psychiatry 162:1385–1386

    PubMed  Google Scholar 

  • Ovaskainen Y, Koponen H, Jokelainen J, Keinanen-Kiukaanniemi S, Kumpusalo E, Vanhala M (2009) Depressive symptomatology is associated with decreased interleukin-1 beta and increased interleukin-1 receptor antagonist levels in males. Psychiatry Res 167:73–79

    CAS  PubMed  Google Scholar 

  • Padmos RC, Hillegers MH, Knijff EM, Vonk R, Bouvy A, Staal FJ, de RD, Kupka RW, Nolen WA, Drexhage HA (2008) A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch Gen Psychiatry 65:395–407

    CAS  PubMed  Google Scholar 

  • Penttinen J (1995) Hypothesis: low serum cholesterol, suicide, and interleukin-2. Am J Epidemiol 141:716–718

    CAS  PubMed  Google Scholar 

  • Plata-Salaman CR (1991) Immunoregulators in the nervous system. Neurosci Biobehav Rev 15:185–215

    CAS  PubMed  Google Scholar 

  • Pugh CR, Nguyen KT, Gonyea JL, Fleshner M, Wakins LR, Maier SF, Rudy JW (1999) Role of interleukin-1 beta in impairment of contextual fear conditioning caused by social isolation. Behav Brain Res 106:109–118

    CAS  PubMed  Google Scholar 

  • Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, Pollmacher T (2001) Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58:445–452

    CAS  PubMed  Google Scholar 

  • Reichenberg A, Kraus T, Haack M, Schuld A, Pollmacher T, Yirmiya R (2002) Endotoxin-induced changes in food consumption in healthy volunteers are associated with TNF-alpha and IL-6 secretion. Psychoneuroendocrinology 27:945–956

    CAS  PubMed  Google Scholar 

  • Robinson CM, Hale PT, Carlin JM (2005) The role of IFN-gamma and TNF-alpha-responsive regulatory elements in the synergistic induction of indoleamine dioxygenase. J Interferon Cytokine Res 25:20–30

    CAS  PubMed  Google Scholar 

  • Rosa A, Peralta V, Papiol S, Cuesta MJ, Serrano F, Martinez-Larrea A, Fananas L (2004) Interleukin-1beta (IL-1beta) gene and increased risk for the depressive symptom-dimension in schizophrenia spectrum disorders. Am J Med Genet B Neuropsychiatr Genet 124:10–14

    Google Scholar 

  • Rothermundt M, Arolt V, Fenker J, Gutbrodt H, Peters M, Kirchner H (2001a) Different immune patterns in melancholic and non-melancholic major depression. Eur Arch Psychiatry Clin Neurosci 251:90–97

    CAS  PubMed  Google Scholar 

  • Rothermundt M, Arolt V, Peters M, Gutbrodt H, Fenker J, Kersting A, Kirchner H (2001b) Inflammatory markers in major depression and melancholia. J Affect Disord 63:93–102

    CAS  PubMed  Google Scholar 

  • Roy A, Pickar D, Paul S, Doran A, Chrousos GP, Gold PW (1987) CSF corticotropin-releasing hormone in depressed patients and normal control subjects. Am J Psychiatry 144:641–645

    CAS  PubMed  Google Scholar 

  • Salzberg-Brenhouse HC, Chen EY, Emerich DF, Baldwin S, Hogeland K, Ranelli S, Lafreniere D, Perdomo B, Novak L, Kladis T, Fu K, Basile AS, Kordower JH, Bartus RT (2003) Inhibitors of cyclooxygenase-2, but not cyclooxygenase-1 provide structural and functional protection against quinolinic acid-induced neurodegeneration. J Pharmacol Exp Ther 306:218–228

    CAS  PubMed  Google Scholar 

  • Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M, Rothman DL, Krystal JH, Mason GF (2004a) Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 61:705–713

    CAS  PubMed  Google Scholar 

  • Sanacora G, Kendell SF, Fenton L, Coric V, Krystal JH (2004b) Riluzole augmentation for treatment-resistant depression. Am J Psychiatry 161:2132

    PubMed  Google Scholar 

  • Sandrini M, Vitale G, Pini LA (2002) Effect of rofecoxib on nociception and the serotonin system in the rat brain. Inflamm Res 51:154–159

    CAS  PubMed  Google Scholar 

  • Sapolsky RM (1985) A mechanism for glucocorticoid toxicity in the hippocampus: increased neuronal vulnerability to metabolic insults. J Neurosci 5:1228–1232

    CAS  PubMed  Google Scholar 

  • Scarr E, Pavey G, Sundram S, MacKinnon A, Dean B (2003) Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder. Bipolar Disord 5:257–264

    CAS  PubMed  Google Scholar 

  • Schäfer M, Horn M, Schmidt F, Schmid-Wendtner MH, Volkenandt M, Ackenheil M, Müller N, Schwarz MJ (2004) Correlation between sICAM-1 and depressive symptoms during adjuvant treatment of melanoma with interferon-alpha. Brain Behav Immun 18:555–562

    Google Scholar 

  • Schiepers OJ, Wichers MC, Maes M (2005) Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 29:201–217

    CAS  PubMed  Google Scholar 

  • Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H (1996a) Increased CD56+ natural killer cells and related cytokines in major depression. Clin Immunol Immunopathol 78:83–85

    CAS  PubMed  Google Scholar 

  • Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H (1996b) Major depressive disorder is associated with elevated monocyte counts. Acta Psychiatr Scand 94:198–204

    CAS  PubMed  Google Scholar 

  • Sluzewska A, Rybakowski J, Bosmans E, Sobieska M, Berghmans R, Maes M, Wiktorowicz K (1996) Indicators of immune activation in major depression. Psychiatry Res 64:161–167

    CAS  PubMed  Google Scholar 

  • Smith RS (1991) The macrophage theory of depression. Med Hypotheses 35:298–306

    CAS  PubMed  Google Scholar 

  • Song C, Leonard BE (2000) Fundamentals of psychoneuroimmunology. Wiley, Chichester

    Google Scholar 

  • Song C, Lin A, Bonaccorso S, Heide C, Verkerk R, Kenis G, Bosmans E, Scharpe S, Whelan A, Cosyns P, De Jongh R, Maes M (1998) The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. J Affect Disord 49:211–219

    CAS  PubMed  Google Scholar 

  • Stein-Behrens BA, Lin WJ, Sapolsky RM (1994) Physiological elevations of glucocorticoids potentiate glutamate accumulation in the hippocampus. J Neurochem 63:596–602

    CAS  PubMed  Google Scholar 

  • Stryjer R, Strous RD, Shaked G, Bar F, Feldman B, Kotler M, Polak L, Rosenzcwaig S, Weizman A (2003) Amantadine as augmentation therapy in the management of treatment-resistant depression. Int Clin Psychopharmacol 18:93–96

    PubMed  Google Scholar 

  • Sundar SK, Cierpial MA, Kilts C, Ritchie JC, Weiss JM (1990) Brain IL-1-induced immunosuppression occurs through activation of both pituitary-adrenal axis and sympathetic nervous system by corticotropin-releasing factor. J Neurosci 10:3701–3706

    CAS  PubMed  Google Scholar 

  • Suzuki T, Ogata A, Tashiro K, Nagashima K, Tamura M, Yasui K, Nishihira J (2000) Japanese encephalitis virus up-regulates expression of macrophage migration inhibitory factor (MIF) mRNA in the mouse brain. Biochim Biophys Acta 1517:100–106

    CAS  PubMed  Google Scholar 

  • Takahashi T, Kimoto T, Tanabe N, Hattori TA, Yasumatsu N, Kawato S (2002) Corticosterone acutely prolonged N-methyl-d-aspartate receptor-mediated Ca2+ elevation in cultured rat hippocampal neurons. J Neurochem 83:1441–1451

    CAS  PubMed  Google Scholar 

  • Trullas R, Skolnick P (1990) Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol 185:1–10

    CAS  PubMed  Google Scholar 

  • Tuominen HJ, Tiihonen J, Wahlbeck K (2006) Glutamatergic drugs for schizophrenia. Cochrane Database Syst Rev 19:CD003730

  • Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, Lalla D, Woolley M, Jahreis A, Zitnik R, Cella D, Krishnan R (2006) Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 367:29–35

    CAS  PubMed  Google Scholar 

  • Vaccarino V, Brennan ML, Miller AH, Bremner JD, Ritchie JC, Lindau F, Veledar E, Su S, Murrah NV, Jones L, Jawed F, Dai J, Goldberg J, Hazen SL (2008) Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: a twin study. Biol Psychiatry 64:476–483

    CAS  PubMed  Google Scholar 

  • Vadalouca A, Moka E, Chatzidimitriou A, Siafaka I, Sikioti P, Argyra E (2009) A randomized, double-blind, placebo-controlled study of preemptively administered intravenous parecoxib: effect on anxiety levels and procedural pain during epidural catheter placement for surgical operations or for chronic pain therapy. Pain Pract 9:181–194

    PubMed  Google Scholar 

  • Weiss JM, Quan N, Sundar SK (1994) Immunological consequences of Interleukin-1 in the brain. Neuropsychopharmacol 10:833

    Google Scholar 

  • Weiss G, Murr C, Zoller H, Haun M, Widner B, Ludescher C, Fuchs D (1999) Modulation of neopterin formation and tryptophan degradation by Th1- and Th2-derived cytokines in human monocytic cells. Clin Exp Immunol 116:435–440

    CAS  PubMed  Google Scholar 

  • Wirtz PH, Redwine LS, Linke S, Hong S, Rutledge T, Greenberg BH, Mills PJ (2010) Circulating levels of soluble intercellular adhesion molecule-1 (sICAM-1) independently predict depressive symptom severity after 12 months in heart failure patients. Brain Behav Immun 24:366–369

    CAS  PubMed  Google Scholar 

  • Woolley CS, Gould E, McEwen BS (1990) Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res 531:225–231

    CAS  PubMed  Google Scholar 

  • Yan QS, Reith ME, Jobe PC, Dailey JW (1997) Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats. Brain Res 765:149–158

    CAS  PubMed  Google Scholar 

  • Yaron I, Shirazi I, Judovich R, Levartovsky D, Caspi D, Yaron M (1999) Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures. Arthritis Rheum 42:2561–2568

    CAS  PubMed  Google Scholar 

  • Yilmaz A, Schulz D, Aksoy A, Canbeyli R (2002) Prolonged effect of an anesthetic dose of ketamine on behavioral despair. Pharmacol Biochem Behav 71:341–344

    CAS  PubMed  Google Scholar 

  • Zarate CA Jr, Payne JL, Quiroz J, Sporn J, Denicoff KK, Luckenbaugh D, Charney DS, Manji HK (2004) An open-label trial of riluzole in patients with treatment-resistant major depression. Am J Psychiatry 161:171–174

    PubMed  Google Scholar 

  • Zarate CA Jr, Quiroz JA, Singh JB, Denicoff KD, De Jesus G, Luckenbaugh DA, Charney DS, Manji HK (2005) An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression. Biol Psychiatry 57:430–432

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-Universität München, Nußbaumstr. 7, 80336, München, Germany

    Norbert Müller, Aye-Mu Myint & Markus J. Schwarz

Authors
  1. Norbert Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aye-Mu Myint
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Markus J. Schwarz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Norbert Müller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Müller, N., Myint, AM. & Schwarz, M.J. Inflammatory Biomarkers and Depression. Neurotox Res 19, 308–318 (2011). https://doi.org/10.1007/s12640-010-9210-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12640-010-9210-2

Keywords

Search

Navigation